Full video transcriptClick to expand
Auto-generated transcript of @daviddemesquita__'s video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00two peptides if your ADHD or ADD that will change your world and they're called C-Max and Salank.
- 0:07Now keep in mind we're constantly blasting ourselves a stimulant when we're ADHD or ADD.
- 0:11That is the traditional medical approach.
- 0:14However, there's some alternate solutions that drive up things like dopamine which help the cognitive focus.
- 0:19The other thing that we run into is when we're taking all these stimulants, we're speeding up our heart rate, increasing anxiety.
- 0:25Which dopamine can do as well but when you're working with peptides that are natural, maybe not so much.
- 0:31So see you next up peptide that drives up dopamine. This is going to help with cognitive focus and the want to get stuff done.
- 0:36Typical of those things is around 500 micrograms up to 2 to 3 times per day.
- 0:42Whereas Salank which is a natural peptide drives up a GABA. GABA is going to be a calming agent.
- 0:48Some people that are ADHD especially are going to be a little bit more on edge, more high strung.
- 0:54And this helps to calm you down a little bit to focus.
- 0:57And something else that's not really talked about is their down regulation of BDNF from all these stimulants that we're taking.
- 1:02So we stopped producing as much serotonin and dopamine.
- 1:05Therefore, doing something like resistance training which has been proven to drive up BDNF extremely effectively
- 1:12can actually help with overall cognitive focus as well as neuroplasticity in the brain which C-Max has been proven to do as well.
- 1:20In fact they use it with stroke victims.
Peptide therapy TikTok claims: what the science actually supports
Quick answer
Semax and Selank are synthetic peptides studied primarily in Russian clinical and preclinical settings for neuroprotection and anxiolysis, respectively, with limited peer-reviewed human trial data available in Western literature. Neither is FDA-approved for ADHD or any other condition, and neither has been evaluated in randomized controlled trials specifically for attention-deficit disorders. Individuals with ADHD who are considering changes to their current treatment protocol should consult a licensed clinician, as unsupervised substitution of prescribed stimulant medication carries real clinical risk.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Peptide therapy TikTok claims: what the science actually supports, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Functional Connectomic Approach to Studying Selank and Semax Effects
Small Russian fMRI study (52 healthy volunteers) of brain connectivity after Semax or Selank; mechanistic and exploratory, not a clinical efficacy trial.
PubMed
Effects of Semax on the Default Mode Network of the Brain
Small human fMRI study (24 adults) of intranasal Semax on brain networks; an imaging-marker study with no clinical outcomes, not replicated outside the originating group.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Peptide therapy TikTok claims: what the science actually supports is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Peptide therapy TikTok claims: what the science actually supports" from David DeMesquita™m. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Semax and Selank are synthetic peptides studied primarily in Russian clinical and preclinical settings for neuroprotection and anxiolysis, respectively, with limited peer-reviewed human trial data available in Western literature.
The reason this review is not generic is the source wording and the canonical claim label "peptides tiktok 7576469790055861535." In this clip, the useful excerpt is: "two peptides if your ADHD or ADD that will change your world and they're called C-Max and Salank." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Functional Connectomic Approach to Studying Selank and Semax Effects (2020), Effects of Semax on the Default Mode Network of the Brain (2018), and Therapeutic Peptides: Applications, Challenges, and Future Directions (2026), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Semax and Selank are synthetic peptides studied primarily in Russian clinical and preclinical settings for neuroprotection and anxiolysis, respectively, with limited peer-reviewed human trial data available in Western literature.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Semax and Selank are synthetic peptides studied primarily in Russian clinical and preclinical settings for neuroprotection and anxiolysis, respectively, with limited peer-reviewed human trial data available in Western literature. Neither is FDA-approved for ADHD or any other condition, and neither has been evaluated in randomized controlled trials specifically for attention-deficit disorders. Individuals with ADHD who are considering changes to their current treatment protocol should consult a licensed clinician, as unsupervised substitution of prescribed stimulant medication carries real clinical risk.
- Neither Semax nor Selank is FDA-approved for ADHD or any condition in the United States, and both lack randomized controlled trial data in human ADHD populations.
- Semax is an ACTH(4-7) analogue with documented dopaminergic and BDNF-modulating effects in animal models, primarily studied in Russia since the 1980s (Shadrina et al., 2010, Journal of Molecular Neuroscience).
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Neither Semax nor Selank is FDA-approved for ADHD or any condition in the United States, and both lack randomized controlled trial data in human ADHD populations.
- Semax is an ACTH(4-7) analogue with documented dopaminergic and BDNF-modulating effects in animal models, primarily studied in Russia since the 1980s (Shadrina et al., 2010, Journal of Molecular Neuroscience).
- Selank has shown GABAergic anxiolytic activity in preclinical research, which is directionally consistent with the creator's claims, but human evidence remains limited to small Russian studies.
- The 'natural equals safer' framing is scientifically unsound. No long-term human safety profile exists for either peptide used as an ADHD intervention.
- Resistance training and aerobic exercise are among the better-supported non-pharmacological interventions for ADHD symptoms. Pontifex et al. (2013, Journal of Pediatrics) found exercise improved attention and inhibitory control in children with ADHD.
- Stimulant medications and BDNF: the relationship is complex and region-specific in animal models, not the clean suppression narrative presented in the video.
- Anyone considering changes to prescribed ADHD medication should work with a licensed clinician. Unilateral substitution of stimulant therapy with unregulated peptides carries real, unquantified risk.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @daviddemesquita__ actually say?
The creator claims that two peptides, Semax and Selank, offer an alternative to traditional ADHD stimulant medications. His core argument is that Semax "drives up dopamine" to improve cognitive focus, while Selank "drives up GABA" to reduce anxiety and hyperarousal. He also argues that stimulant medications suppress BDNF production, reducing serotonin and dopamine over time, and that Semax has been "proven" to support neuroplasticity, even in stroke patients. These are bold, specific claims about mechanisms of action and clinical outcomes.
He also brings in resistance training as a BDNF booster, which is a reasonable pivot. But the peptide-specific claims carry more weight in this video, and those deserve a harder look.
Does the science back this up?
Partially, but the research base is thin, mostly preclinical, and almost entirely from Russian and Eastern European studies with small samples and limited independent replication. That context matters enormously.
Semax is a synthetic analogue of ACTH(4-7), developed in Russia in the 1980s. There is legitimate research showing it influences dopaminergic and serotonergic systems and has neuroprotective properties. Shadrina et al. (2010, Journal of Molecular Neuroscience) found Semax modulated BDNF expression in rat models. Its use in Russian clinics for stroke recovery is real, though the evidence standards there differ from FDA-level trials. Selank is a synthetic analogue of tuftsin with documented anxiolytic effects, also studied primarily in Russia. Seredenin and Voronin (2009, Eksperimental'naya i Klinicheskaya Farmakologiya) described GABAergic modulation and anxiety reduction in animal models. Calling either peptide "proven" for ADHD in humans, however, is a stretch the data simply does not support.
What did they get wrong (or right)?
He got a few things directionally right. Selank does appear to have anxiolytic properties linked to GABAergic activity, and that mechanism is reasonably characterized here. The claim that resistance training boosts BDNF is well-supported. Sleiman et al. (2016, Cell Metabolism) demonstrated that exercise-induced lactate promotes BDNF expression. Credit where it is due.
But there are real problems. The claim that Semax "drives up dopamine" is an oversimplification. Semax appears to modulate the dopaminergic system indirectly, not through a straightforward agonist mechanism. Comparing that to how stimulants like amphetamine work is not apples to apples. More concerning is the framing that peptides are "natural" and therefore carry fewer cardiovascular or anxiety risks than stimulants. That logic does not hold scientifically. "Natural" does not mean safe or side-effect-free, and there are no long-term human safety data on intranasal Semax or Selank for ADHD. Presenting them as a low-risk swap for prescribed ADHD medication, without that caveat, is misleading.
The claim that stimulants cause "downregulation of BDNF" is also presented as established fact. The evidence here is mixed. Some preclinical data suggest chronic amphetamine use can affect BDNF expression, but the human clinical picture is not that clean.
What should you actually know?
Neither Semax nor Selank is FDA-approved for any indication in the United States. Both exist in a regulatory gray zone and are not approved treatments for ADHD. If you have ADHD and are considering replacing or supplementing your medication, that conversation belongs with a licensed clinician who has access to your full medical history, not a TikTok video.
The broader point about exploring alternatives to stimulant-based ADHD management is legitimate and worth discussing with a provider. Some people do poorly on stimulants due to cardiovascular sensitivity or anxiety. But moving from that real problem to "use these unregulated peptides instead" is a leap the current evidence cannot support.
The resistance training recommendation is genuinely good advice and one of the more evidence-backed cognitive interventions available. Pontifex et al. (2013, Journal of Pediatrics) found aerobic exercise improved attention and inhibitory control in children with ADHD. That part of the video holds up better than the peptide claims.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
David DeMesquita™m · TikTok creator
7.9K views on this video
Peptide therapy TikTok claims: what the science actually supports
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about neither semax nor selank?
Neither Semax nor Selank is FDA-approved for ADHD or any condition in the United States, and both lack randomized controlled trial data in human ADHD populations.
What does the video say about semax?
Semax is an ACTH(4-7) analogue with documented dopaminergic and BDNF-modulating effects in animal models, primarily studied in Russia since the 1980s (Shadrina et al., 2010, Journal of Molecular Neuroscience).
What does the video say about selank has shown gabaergic anxiolytic activity in preclinical research,?
Selank has shown GABAergic anxiolytic activity in preclinical research, which is directionally consistent with the creator's claims, but human evidence remains limited to small Russian studies.
What does the video say about the 'natural equals safer' framing?
The 'natural equals safer' framing is scientifically unsound. No long-term human safety profile exists for either peptide used as an ADHD intervention.
What does the video say about resistance training?
Resistance training and aerobic exercise are among the better-supported non-pharmacological interventions for ADHD symptoms. Pontifex et al. (2013, Journal of Pediatrics) found exercise improved attention and inhibitory control in children with ADHD.
What does the video say about stimulant medications?
Stimulant medications and BDNF: the relationship is complex and region-specific in animal models, not the clean suppression narrative presented in the video.
Sources & references
- [1]Shadrina et al. (2010)
- [2]Sleiman et al. (2016)
- [3]Pontifex et al. (2013)
- [4]Seredenin and Voronin (2009)
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by David DeMesquita™m, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.